| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.016 | 0.9 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.0021 | 0.9 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | 0.013 | 1 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |